Raquel Menezes Fernandes

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Aortic Stenosis

Hypertrophic Cardiomyopathy

Top Venues

Future cardiology

The international journal of cardiovascular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Tamara Pereira, Raquel Menezes Fernandes, Emídio Mata, Olga Azevedo, Dina Bento, Ilídio Jesus, António Lourenço
Transthyretin amyloid cardiomyopathy in severe aortic stenosis submitted to valve replacement: a multicenter study. Future cardiology (2024)
Raquel Menezes Fernandes, Mariana Brandão, Ricardo Ladeiras Lopes, Rita Faria, Nuno Dias Ferreira, Ricardo Fontes-Carvalho
Myocardial deformation analysis using cardiac magnetic resonance in apical hypertrophic cardiomyopathy: is it an useful tool to predict adverse outcomes? The international journal of cardiovascular imaging (2023)
Raquel Menezes Fernandes, Dina Bento, Nuno Marques, Olga Azevedo, Teresa Mota, Hugo Costa, Miguel Espírito Santo, Daniela Carvalho Silva, Ilídio Jesus
Challenges in Fabry disease: the combination of two individually amenable GLA variants may be nonamenable to migalastat. Future cardiology 19 (1) (2023)
Raquel Menezes Fernandes, Dina Bento, Nuno Marques, Olga Azevedo, Teresa Mota, Hugo Costa, Miguel Espírito Santo, Daniela Carvalho Silva, Ilídio Jesus
Challenges in Fabry disease: the combination of two individually amenable GLA variants may be nonamenable to migalastat. Future cardiology 19 (1) (2023)
Raquel Menezes Fernandes, Dina Bento, Nuno Marques, Olga Azevedo, Teresa Mota, Hugo Costa, Miguel Espírito Santo, Daniela Carvalho Silva, Ilídio Jesus
Challenges in Fabry disease: the combination of two individually amenable GLA variants may be nonamenable to migalastat. Future cardiology (2023)
Raquel Menezes Fernandes, Dina Bento, Nuno Marques, Olga Azevedo, Teresa Mota, Hugo Costa, Miguel Espírito Santo, Daniela Carvalho Silva, Ilídio Jesus
Challenges in Fabry disease: the combination of two individually amenable GLA variants may be nonamenable to migalastat. Future cardiology 19 (1) (2023)